SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-228185
Filing Date
2021-07-29
Accepted
2021-07-29 07:36:01
Documents
14
Period of Report
2021-07-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d200489d8k.htm   iXBRL 8-K 27586
2 EX-99.1 d200489dex991.htm EX-99.1 11349
6 GRAPHIC g200489g0729045142093.jpg GRAPHIC 4451
  Complete submission text file 0001193125-21-228185.txt   173073

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kura-20210728.xsd EX-101.SCH 2904
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20210728_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20210728_pre.xml EX-101.PRE 11416
7 EXTRACTED XBRL INSTANCE DOCUMENT d200489d8k_htm.xml XML 3359
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37620 | Film No.: 211124849
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences